Centene eyes 2027 turnaround amid Medicare Advantage payment tailwinds and strategic membership optimization. FY2026 may see a trough as the company refines its base, supporting future margin improvement. Attractive valuation with 3-year PEG of 0.35x signals upside if momentum shifts. #medicareadvantage #healthcarestocks
